Thompson G K, O'Brien P Q, Chen K W. "Method for the Synthesis of 65717-97-7
4V891LH5NB
Disofenin [USAN:INN:BAN]
Disofenin
Glycine, N-(2-((2,6-bis(1-methylethyl)phenyl)amino)-2-oxoethyl)-N-(carboxymethyl)-
((((2,6-Diisopropylphenyl)carbamoyl)methyl)imino)diacetic acid
Disofenine [INN-French]
Disofenino [INN-Spanish]
Disofeninum [INN-Latin]
Disofenine
Disofenino
Disofeninum
UNII-4V891LH5NB
DSIDA" [P]. US Patent, US 11249199 B2, 2021-06-28.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of 地索苯宁 in Pharmaceutical Formulations". Sci. Total Environ., 2018, 1698, (6), 3908-3922.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of 地索苯宁 as an Impurity". J. Agric. Food Chem., 2025, 1594, (12), 2671-2675.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 65717-97-7
4V891LH5NB
Disofenin [USAN:INN:BAN]
Disofenin
Glycine, N-(2-((2,6-bis(1-methylethyl)phenyl)amino)-2-oxoethyl)-N-(carboxymethyl)-
((((2,6-Diisopropylphenyl)carbamoyl)methyl)imino)diacetic acid
Disofenine [INN-French]
Disofenino [INN-Spanish]
Disofeninum [INN-Latin]
Disofenine
Disofenino
Disofeninum
UNII-4V891LH5NB
DSIDA Using HRMS and NMR". Biomed. Chromatogr., 2012, 1914, (9), 9514-9517.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 地索苯宁 Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2022, 588, 4051-4075.